Pharmaceutical manufacturing demands the highest standards of temperature control, process reliability, and product integrity. From raw material storage to finished product distribution, maintaining precise thermal conditions is essential for meeting GMP requirements and ensuring patient safety. At the heart of every reliable cold chain system lies an effective secondary refrigerant — and Glacier Coolant LM-4 sets the industry standard.

Unlike conventional refrigerants that degrade over time and compromise system performance, LM-4 delivers consistent thermal performance while protecting equipment from corrosion and extending operational lifespan.

30+
Years of Industry Experience
455→60
Iron Ion Reduction (mg/L)
10+
Year Service Lifespan

The Critical Role of Secondary Refrigerants in Pharma

Secondary refrigerants serve as the thermal transport medium in pharmaceutical cooling systems, transferring heat between process equipment and refrigeration units. The ideal secondary refrigerant must balance multiple requirements:

  • Wide Operating Range: Support temperatures from cryogenic (-80°C) to process heating (150°C)
  • Chemical Stability: Resist degradation and maintain properties over time
  • Material Compatibility: Not cause corrosion or damage to system components
  • Thermal Efficiency: Maximize heat transfer with minimal energy consumption
  • Safety: Non-flammable, non-toxic, and environmentally responsible

LM-4: The Advanced Solution for Pharmaceutical Applications

Glacier Coolant LM-4 addresses these requirements through a proprietary formulation that combines three core technologies:

1. M3 Ultra-Film Anti-Corrosion Technology

This innovative technology creates a protective molecular layer on all metal surfaces, preventing oxidation and corrosion. Unlike traditional inhibitors that deplete over time, M3 technology maintains its protective properties throughout the fluid’s lifespan.

2. Modify2000 Composite Modification

Through advanced chemical modification, LM-4 achieves exceptional thermal stability across its entire operating range (-35°C to 150°C). This ensures consistent performance in both cooling and heating applications.

3. Box7 Comprehensive Testing System

Every batch of LM-4 undergoes rigorous quality control testing, including gas chromatography-mass spectrometry, freezing point analysis, thermal conductivity measurement, and specific heat capacity verification.

Technical Performance Comparison

Property LM-4 Glacier Coolant Ethylene Glycol (55%) Calcium Chloride Brine
Freezing Point -42.5°C -41.1°C -41°C
Specific Heat (-30°C) 0.72 Cal/g°C 0.718 Cal/g°C 0.65 Cal/g°C
Viscosity (-30°C) 43.57 cP 49.3 cP 18 cP
Corrosion Protection Excellent Poor Severe

Case Study: Yuntianhua Group Pentaerythritol Plant

case1

200 m³ Cooling System Transformation
Detailed Analysis

Project Overview: Yuntianhua Group’s pentaerythritol manufacturing plant operated a 200 m³ ethylene glycol cooling system for its production process at -10°C. Within two years of commissioning, the system experienced severe corrosion that threatened production continuity.

Corrosion Impact: Annual maintenance required removing over 1 ton of rust sludge from the system. Iron ion concentration in the ethylene glycol exceeded 455-838 mg/L, indicating aggressive corrosion that was thinning pipe walls and damaging heat exchangers.

Conversion to LM-4: The plant replaced the entire ethylene glycol system with LM-4 Glacier Coolant. The conversion process included system flushing, corrosion inhibitor removal, and LM-4 filling at optimal concentration.

Performance Monitoring: Over 17 months of continuous operation, regular testing showed iron ion levels remained stable at 60-127 mg/L — a significant reduction from the previous 455-838 mg/L. This demonstrated LM-4′s superior corrosion protection capabilities.

Key Benefits Achieved:

  • Eliminated annual rust sludge removal (1 ton+)
  • Reduced iron ion concentration by 85%
  • Eliminated corrosion-related equipment failures
  • Extended equipment maintenance intervals

Additional Success Stories

LM-4 has delivered similar results across various pharmaceutical and chemical manufacturing facilities:

Daqing Petrochemical Polymer Plant

Mixed ethylene glycol and brine systems suffered progressive pipe wall thinning and heat exchanger leaks between 2013-2018. After upgrading to 35% LM-4, corrosion-related failures were eliminated and refrigeration unit performance stabilized.

Zhejiang Chengda Pharmaceutical

High-low temperature switching system (-20°C to 120°C) replaced brine+steam with LM-4 as a single medium, enabling automated temperature switching and improving process stability.

Key Benefits for Pharmaceutical Operations

Complete System Protection

LM-4 protects all metal surfaces including carbon steel, stainless steel, copper, and aluminum without causing galvanic corrosion.

Extended Equipment Life

With proper maintenance, LM-4 systems operate reliably for 10+ years, reducing capital expenditure on equipment replacement.

Energy Efficiency

Lower viscosity and better thermal conductivity reduce pump energy requirements and improve heat transfer efficiency.

Environmental Compliance

ODP=0, GWP=7, and fully recyclable, LM-4 meets international environmental standards without compromising performance.

Quality Certification and Assurance

Glacier Coolant LM-4 has received comprehensive third-party certification:

  • Non-Corrosion Test: Verified per JB/T 7901-1999 standard
  • Flash Point Identification: Confirmed non-flammable
  • Chemical Physical Hazard Assessment: No physical hazards
  • Fire Classification: Safe handling classification
  • Toxicological Assessment: Practically non-toxic

Improve Your Pharmaceutical Cooling System Today

Experience the benefits of LM-4 Glacier Coolant in your pharmaceutical cold chain operations. Our technical experts will conduct a comprehensive assessment of your current system and recommend the optimal solution.

Request Expert Consultation

Common Questions About LM-4

Q: Can LM-4 be used in existing pharmaceutical cooling systems?
A: Yes, LM-4 is compatible with all standard industrial materials used in pharmaceutical cooling systems. Most systems can be converted to LM-4 with minimal preparation and no equipment modification.
Q: What concentration of LM-4 is recommended for pharmaceutical applications?
A: Typical concentrations range from 35-55%, depending on the required freezing point. For most pharmaceutical processes operating between -20°C and 50°C, a 35-40% concentration is recommended.
Q: How does LM-4 compare to propylene glycol for pharmaceutical use?
A: While propylene glycol is non-toxic, it still corrodes metal surfaces over time and has higher viscosity at low temperatures, reducing heat transfer efficiency. LM-4 provides superior corrosion protection and better overall performance.
Q: What maintenance is required for LM-4 systems?
A: LM-4 requires minimal maintenance. Periodic testing (every 6-12 months) of pH, concentration, and ion levels is recommended to ensure optimal performance.

Data Sources: All product specifications and case study data presented in this article are sourced from Glacier Coolant technical documentation, third-party laboratory testing reports, and verified customer case studies. Performance data follows JB/T 7901-1999 and GB/T 50050-2017 industry standards.